Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
71.30
+0.36 (0.50%)
Jul 30, 2026, 10:16 AM EDT - Market open
Utah Medical Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 36.11 | 38.52 | 40.9 | 50.22 | 52.28 | 49.05 | |
Revenue Growth | -7.00% | -5.83% | -18.56% | -3.94% | 6.58% | 16.30% |
Cost of Revenue | 11.43 | 16.52 | 16.76 | 20.19 | 20.09 | 18.14 |
Gross Profit | 20.91 | 22 | 24.14 | 30.04 | 32.2 | 30.92 |
Selling, General & Admin | 2.56 | 9.93 | 9.74 | 12.7 | 11.91 | 11.51 |
Research & Development | - | 0.67 | 0.81 | 0.56 | 0.49 | 0.53 |
Total Operating Expenses | 2.56 | 10.6 | 10.55 | 13.26 | 12.41 | 12.04 |
Operating Income | 10.27 | 11.4 | 13.59 | 16.78 | 19.79 | 18.88 |
Interest Income | - | 2.83 | 3.38 | 3.06 | 0.68 | 0.18 |
Other Non-Operating Income (Expense) | - | -0.12 | -0.17 | 0.26 | 0.19 | - |
Total Non-Operating Income (Expense) | 1.32 | 2.71 | 3.21 | 3.31 | 0.87 | 0.18 |
Pretax Income | 12.88 | 14.11 | 16.8 | 20.09 | 20.66 | 19.06 |
Provision for Income Taxes | 1.8 | 2.82 | 2.93 | 3.45 | 4.19 | 4.27 |
Net Income | 5.32 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 |
Net Income to Common | 5.32 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 |
Net Income Growth | -19.57% | -18.65% | -16.60% | 0.98% | 11.39% | 36.95% |
Shares Outstanding (Basic) | 3 | 3 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 3 | 3 | 4 | 4 | 4 | 4 |
Shares Change | -4.83% | -7.51% | -3.68% | -0.17% | -0.46% | -0.33% |
EPS (Basic) | 3.29 | 3.48 | 3.96 | 4.58 | 4.53 | 4.05 |
EPS (Diluted) | 3.29 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 |
EPS Growth | -12.07% | -12.12% | -13.35% | 1.11% | 11.88% | 37.41% |
Free Cash Flow | - | 14.32 | 14.6 | 21.64 | 20.34 | 20.65 |
Free Cash Flow Growth | - | -1.92% | -32.53% | 6.41% | -1.52% | 7.13% |
Free Cash Flow Per Share | - | 4.42 | 4.17 | 5.95 | 5.58 | 5.64 |
Dividends Per Share | 0.615 | 1.225 | 1.205 | 1.185 | 1.165 | 0.855 |
Dividend Growth | -49.38% | 1.66% | 1.69% | 1.72% | 36.26% | -23.66% |
Gross Margin | 57.90% | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% |
Operating Margin | 28.43% | 29.60% | 33.23% | 33.40% | 37.85% | 38.49% |
Profit Margin | 14.73% | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
FCF Margin | - | 37.18% | 35.70% | 43.09% | 38.90% | 42.10% |
EBITDA | 10.27 | 14.41 | 16.44 | 23.15 | 26.87 | 26.16 |
EBITDA Margin | 28.43% | 37.41% | 40.19% | 46.08% | 51.40% | 53.34% |
EBIT | 10.27 | 11.4 | 13.59 | 16.78 | 19.79 | 18.88 |
EBIT Margin | 28.43% | 29.60% | 33.23% | 33.40% | 37.85% | 38.49% |
Effective Tax Rate | 13.94% | 20.01% | 17.43% | 17.19% | 20.26% | 22.42% |